Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets ...

As the holidays bring family and friends together, joyful gatherings can be followed by days and weeks of illness. Cases of ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The 2024-2025 COVID-19 vaccination composition was changed this year to include a new variant more closely related to the ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...

As of late October, the CDC recommends a second dose of the 2024-2025 COVID-19 vaccine for at-risk groups. Here's what you ...

But what kind of sickness do your symptoms point to? Here's a breakdown for COVID-19, flu and more — and why testing is so ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

S eniors and people who are immunocompromised should get not just one but two COVID-19 shots this respiratory virus season. That's the new recommendation from the U.S. Centers for Disease Control and ...

By Jack Phillips Contributing Writer Recent estimates published by the U.S. Centers for Disease Control and Prevention show ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons.